Mizuho Maintains Outperform on Chemours, Lowers Price Target to $25

Chemours Co.

Chemours Co.

CC

0.00

Mizuho analyst John Roberts maintains Chemours (NYSE: CC) with a Outperform and lowers the price target from $30 to $25.